These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The primary and memory immune response to Epstein-Barr virus infection in vitro is characterized by a divergent production of IL-1beta/IL-6 and IL-10. Jabs WJ; Wagner HJ; Schlenke P; Kirchner H Scand J Immunol; 2000 Sep; 52(3):304-8. PubMed ID: 10972908 [TBL] [Abstract][Full Text] [Related]
27. T cell epitope screening of Epstein-Barr virus fusion protein gB. Chen H; Zhang X; Zhang S; Duan X; Xiang T; Zhou X; Zhang W; Zhang X; Feng Q; Kang Y; Li J; Deng L; Wang L; Lv X; Zeng M; Zeng YX; Xu M J Virol; 2021 Apr; 95(10):. PubMed ID: 33658348 [TBL] [Abstract][Full Text] [Related]
28. EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Glaser R; Litsky ML; Padgett DA; Baiocchi RA; Yang EV; Chen M; Yeh PE; Green-Church KB; Caligiuri MA; Williams MV Virology; 2006 Mar; 346(1):205-18. PubMed ID: 16321417 [TBL] [Abstract][Full Text] [Related]
29. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection. Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients. Kianfar R; Ravanshad M; Ghiass MA; Rafiee N; Shayeghpour A; Maleki A Intervirology; 2022; 65(3):144-150. PubMed ID: 35158367 [TBL] [Abstract][Full Text] [Related]
31. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321 [TBL] [Abstract][Full Text] [Related]
32. Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapy. He J; Tang XF; Chen QY; Mai HQ; Huang ZF; Li J; Zeng YX Chin J Cancer; 2012 Jun; 31(6):287-94. PubMed ID: 22257383 [TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells. Ariza ME; Rivailler P; Glaser R; Chen M; Williams MV PLoS One; 2013; 8(7):e69827. PubMed ID: 23894549 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. Ohga S; Nomura A; Takada H; Ihara K; Kawakami K; Yanai F; Takahata Y; Tanaka T; Kasuga N; Hara T J Infect Dis; 2001 Jan; 183(1):1-7. PubMed ID: 11106535 [TBL] [Abstract][Full Text] [Related]
35. Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C. Shimozuma Y; Ito T; Inokuchi M; Uchikoshi M; Miyashita M; Nozawa H; Shimazaki T; Hiroishi K; Imawari M J Med Virol; 2010 Dec; 82(12):2064-72. PubMed ID: 20981794 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879 [TBL] [Abstract][Full Text] [Related]
37. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression. Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217 [TBL] [Abstract][Full Text] [Related]
39. Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytes. Kosmas C; Epenetos AA; Courtenay-Luck NS Leuk Lymphoma; 1992 Sep; 8(1-2):109-15. PubMed ID: 1337296 [TBL] [Abstract][Full Text] [Related]
40. [Expression Profile and Clinical Significance of Cytokines and Chemokines in Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis]. Gao Y; Zheng Y; Zhang WH; Li Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):268-273. PubMed ID: 36765510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]